Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Lupin appoints Alok Sonig as CEO - US Generics and Global Head - Generics R&D & Biosimilars

Posted On: 2018-09-19 06:30:20

Lupin Limited announced the appointment of Alok Sonig as CEO - US Generics and Global Head - Generics R&D & Biosimilars. Alok will lead and have overall responsibility for the US Generics business including Research & Development in India and the US and the Commercial side of the business in the US. He will also be responsible for Lupin's global Biosimilars business.

With over 23 years of experience in the industry, Alok brings an established track record of success in the Pharmaceutical and Healthcare sectors to Lupin. Most recently, Alok was CEO of Developed Markets (US, Canada, Europe and Japan) at Dr. Reddy's. He joined Dr. Reddy's in 2012 and ran their India business till 2015 before moving back to the US to run their North America business. Prior to Dr. Reddy's, Alok spent nearly 15 years at Bristol-Myers Squibb, where he held several positions of increasing responsibilities in General Management, Country leadership roles, Global Strategy and Marketing. Alok holds a Bachelor's of Engineering from Punjab Engineering College in India, and an MBA from American University, Washington, D.C.

Commenting on the appointment, Ms. Vinita Gupta, Chief Executive Officer, and Mr. Nilesh Gupta, Managing Director, Lupin said, "We are delighted to welcome Alok to Lupin. His global experience, strategic perspective, and operational focus will help accelerate our team's efforts to strengthen and evolve our US generics business as we execute on near-term growth opportunities and navigate new platforms in complex generics and biosimilars."

Alok will be based out of Somerset, New Jersey and split his time between Lupin's Somerset, Baltimore and India offices. He will report to Ms. Vinita Gupta - Chief Executive Officer, Lupin and Mr. Nilesh Gupta - Managing Director, Lupin.

Shares of LUPIN LTD. was last trading in BSE at Rs.929.7 as compared to the previous close of Rs. 948.75. The total number of shares traded during the day was 163377 in over 3720 trades.

The stock hit an intraday high of Rs. 963 and intraday low of 927. The net turnover during the day was Rs. 154369841.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Strides receives USFDA approval for Gabapentin Capsules

JSW Steel Ltd board to consider raising long term resources on Oct 25, 2018

HDFC Bank announces Q2 FY19 results

Srei Infrastructure Finance Ltd clarifies on rumours

UCO Bank designates Sri Ram Kumar as CFO

Triveni Turbine Ltd board to approve 2nd quarter results on Nov 1, 2018

Nitin Spinners Ltd board to consider second quarter results on Oct 31, 2018

Deepak Spinners Ltd board to announce 2nd quarter results on Nov 5, 2018

HPL Electric & Power Ltd board to approve Q2 FY19 results on Oct 29, 2018

Kirloskar Pneumatic Company Ltd board to consider Q2, H1 results on Nov 2, 2018

Welspun Enterprises Ltd calls for board meeting on Oct 30, 2018 to approve Q2 results

Lakshmi Mills Company Ltd board to announce Q2 FY19 results on Nov 14, 2018

Shreyans Industries Ltd board to consider quarterly results on Nov 13, 2018

Bank of Maharashtra Ltd calls for board meeting on Oct 30, 2018

Maithan Alloys Ltd board to approve Q2, H1 results on Oct 29, 2018

Fine Organic Industries Ltd board to announce 2nd quarter results on Nov 2, 2018

Wonderla Holidays Ltd board to consider Q2 FY19 results on Oct 29, 2018

Dena Bank Ltd calls for board meeting on Oct 30, 2018

Adani Enterprises Ltd board to announce quarterly results on Oct 31, 2018

Biocon and Mylan Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab

Adani Green Energy Ltd board to approve 2nd quarter results on Oct 31, 2018

Adani Power Ltd board to consider Q2 results on Oct 31, 2018

Tube Investments of India Ltd calls for board meeting on Nov 2, 2018

Edelweiss Financial Services Ltd to announce Q2 FY19 results on Oct 26, 2018

Zydus Wellness Ltd calls for board meeting on Nov 2, 2018 to consider Q2 results

Aurionpro Solutions Ltd board to consider 2nd quarter results on Oct 27, 2018

Just Dial Ltd board to approve Q2 results on Oct 29, 2018

Bajaj Electricals Ltd board to announce Q2, H1 FY19 results on Nov 1, 2018

Voltamp Transformers Ltd board to consider Q2 FY19 results on Nov 1, 2018

TGV Sraac Ltd board to approve second quarter results on Oct 27, 2018

JSW Energy Ltd board to announce 2nd quarter results on Nov 2, 2018

Pioneer Embroideries Ltd calls for board meeting on Oct 28, 2018

JSW Holdings Ltd board to consider Q2 results on Nov 3, 2018

Bhansali Engineering Polymers Ltd Q2 net profit slides to Rs. 16.88 crores

Sadhana Nitrochem Ltd continues its dream performance in Q2 FY19

NELCO Ltd Q2 net profit jumps to Rs. 10.09 crores

Bhageria Industries Ltd Q2 PAT zooms to Rs. 28.21 crores

MPS Ltd Q2 FY19 consolidated net up at Rs. 18.67 crores

Smruthi Organics Ltd Q2 PAT jumps Y-o-Y to Rs. 1.03 crore

HDFC Bank Ltd Q2 FY19 net profit climbs to Rs. 5005.73 crores

Pudumjee Paper Products Ltd reports higher Q2 net profit of Rs. 5.75 crore

Srikalahasthi Pipes Limited board to approve Q2 FY19 results on Oct 31, 2018

Sasan Power Limited wins arbitration award against NACC

EROS International Media Ltd board to announce Q2, H1 FY19 results on Oct 26, 2018

OnMobile Global Ltd board to consider 2nd quarter results on Oct 29, 2018

Bodal Chemicals Ltd calls for board meeting on Oct 25, 2018

Butterfly Gandhimathi Appliances Ltd board to announce second quarter results on Oct 31, 2018

Merck Ltd board to approve quarterly results on Oct 30, 2018

Savita Oil Technologies Ltd board to consider Q2 FY19 results on Nov 3, 2018

VTM Ltd posts jump in Q2 PAT to Rs. 3.93 crore







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2018